Paolo Fraticelli Selected Research

Paolo Fraticelli Research Topics

9	Vasculitis (Vasculitides) 12/2023 - 09/2015
6	Churg-Strauss Syndrome (Allergic Angiitis) 12/2023 - 01/2021
6	Systemic Scleroderma (Systemic Sclerosis) 02/2020 - 06/2006
3	Cryoglobulinemia 02/2023 - 01/2021
3	Fibrosis (Cirrhosis) 01/2020 - 07/2015
3	Multiple Myeloma 12/2012 - 06/2010
2	Asthma (Bronchial Asthma) 12/2023 - 12/2023
2	Systemic Vasculitis 04/2023 - 06/2021
2	Autoimmune Diseases (Autoimmune Disease) 03/2021 - 06/2006
2	Infections 09/2015 - 05/2011
1	Eosinophilia 12/2023
1	Inflammation (Inflammations) 01/2023
1	Vascular Skin Diseases 01/2023
1	Hepatitis B 06/2021
1	Rheumatoid Arthritis 01/2021
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021
1	Disease Progression 02/2020
1	Dyspepsia (Indigestion) 01/2019
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2019
1	digital ulcers 09/2017
1	Splenomegaly 03/2017
1	Purpura 03/2017
1	Sjogren's Syndrome (Sjogren Syndrome) 03/2017
1	Lymphadenopathy 03/2017
1	Fatigue 03/2017
1	Arthralgia (Joint Pain) 03/2017
1	Chronic Hepatitis (Chronic Active Hepatitis) 12/2016
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 10/2016
1	Agammaglobulinemia (Hypogammaglobulinemia) 09/2015
1	Pain (Aches) 01/2015
1	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2014
1	Skin Manifestations 05/2012
1	Neoplasms (Cancer) 05/2011
1	Pneumonia (Pneumonitis) 05/2011

7	Rituximab (Mabthera)FDA Link 02/2023 - 07/2015
5	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2023 - 05/2012
3	Prednisone (Sone)FDA LinkGeneric 12/2023 - 01/2022
2	dupilumabIBA 12/2023 - 01/2023
2	benralizumabIBA 12/2023 - 01/2023
2	Antigen-Antibody Complex (Immune Complex)IBA 04/2023 - 02/2023
2	CryoglobulinsIBA 02/2023 - 03/2017
2	mepolizumabIBA 01/2023 - 01/2022
2	AutoantibodiesIBA 06/2021 - 06/2006
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 07/2018 - 12/2016
2	Imatinib Mesylate (Gleevec)FDA Link 10/2016 - 07/2014
1	GlucocorticoidsIBA 12/2023
1	Interleukin-5 (Interleukin 5)IBA 12/2023
1	Prednisolone (Predate)FDA LinkGeneric 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 06/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2021
1	AntibodiesIBA 06/2021
1	Immunoglobulin A (IgA)IBA 06/2021
1	Complement System Proteins (Complement)IBA 06/2021
1	VaccinesIBA 03/2021
1	Biosimilar PharmaceuticalsIBA 01/2021
1	CT-P10IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 02/2020
1	BilirubinIBA 01/2020
1	GastrinsIBA 01/2019
1	Chromogranin AIBA 01/2019
1	Proton Pump InhibitorsIBA 01/2019
1	Carbon MonoxideIBA 07/2018
1	Iloprost (Ventavis)FDA Link 09/2017
1	Rheumatoid FactorIBA 03/2017
1	Collagen Type I (Type I Collagen)IBA 07/2015
1	Analgesics (Analgesic Drugs)IBA 01/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2014
1	Drug CombinationsIBA 05/2011
1	Thalidomide (Thalomid)FDA Link 05/2011
1	Immunoglobulin G (IgG)IBA 06/2006
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 06/2006